Cristina Rizza, M.D.
Chief Medical Officer and Director
Marc Horwitz, R.Ph.
Pharmacist
Kennedy Matsagas
Biologist and Laboratory Director
Tony Long is a Professor of Biology at the University of California, Irvine. Dr. Long’s expertise is in genomics, including “association” studies required to connect specific genes to human aging. He is one of a handful of leaders in the analysis of genomic data. Tony is responsible for Genescient’s Genomics and Bioinformatics functions. He directs the genomic aspects of the company’s Research and Development, from gene expression in Drosophila to associations between human genes and aging.
Dr. Goertzel is the founder and CEO of SingularityNET, a blockchain-based AI marketplace. Goertzel is also the Chief Scientist of financial prediction firm Aidyia Holdings and robotics firm Hanson Robotics; Chairman of AI software company Novamente LLC, which is a privately held software company; Chairman of the Artificial General Intelligence Society and the OpenCog Foundation; Vice Chairman of futurist nonprofit Humanity+; Research Professor in the Fujian Key Lab for Brain-Like Intelligent Systems at Xiamen University, China; and general Chair of the Artificial General Intelligence conference series, an American author and researcher in the field of artificial intelligence. He was the Director of Research of the Machine Intelligence Research Institute (formerly the Singularity Institute).
Cristina Rizza, M.D.
Chief Medical Officer and Director
Dr Rizza is an Internist and a Cardiologist. She has spent the past thirty years caring for mostly geriatric patients and has a life-long interest in the molecular genetics of aging. Dr. Rizza graduated Summa cum Laude from the University of Bologna, Italy in 1975. After moving to the U.S. in 1976, she received her training in Internal Medicine at the Long Island College Hospital in Brooklyn, New York and her Cardiology training at the UCLA VA program in Los Angeles. The author of several published papers, she has experience in basic and clinical research as-well-as drug testing for efficacy and toxicity.
In her role as Chief Medical Officer, Dr. Rizza is responsible for the biological and clinical annotation of Genescient’s inventory of genes associated with the diseases of aging. She is also involved in the selection of therapeutics for testing and in the recruitment and testing of successful therapeutic substance candidates in human subjects.
Larry Mueller is a Professor of Ecology and Evolutionary Biology at the University of California, Irvine. He received his Ph.D. in 1979 from the University of California, Davis, where he studied under Francisco Ayala. Mueller then went on to do postdoctoral research in theoretical population genetics with Marcus Feldman at Stanford University.
Prior to joining the faculty of the University of California, Irvine, Dr. Mueller was an Assistant and Associate Professor at Washington State University. Mueller has published over 70 papers in the fields of evolution, population, genetics and population ecology. He is also the author of Stability in Model Populations with Amitabh Joshi.
In his current research, Dr. Mueller applies experimental evolution to study problems like density-dependent natural selection and the evolution of late-life demographic patterns in Drosophila.
Dr. Greer is a Genomicist, Evolutionary Biologist and Phylogeneticist, at the University of California, Riverside.
Marc Horwitz, R.Ph.
Pharmacist